SARTORELLO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 2.168
AS - Asia 873
EU - Europa 542
AF - Africa 221
SA - Sud America 202
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 7
Totale 4.032
Nazione #
US - Stati Uniti d'America 2.074
SG - Singapore 342
CN - Cina 177
BR - Brasile 125
VN - Vietnam 96
HK - Hong Kong 77
FI - Finlandia 54
DE - Germania 51
IT - Italia 49
SE - Svezia 47
GB - Regno Unito 40
PL - Polonia 31
FR - Francia 28
RU - Federazione Russa 21
NL - Olanda 19
UA - Ucraina 18
CI - Costa d'Avorio 16
EC - Ecuador 16
TR - Turchia 16
BE - Belgio 13
MX - Messico 13
ZA - Sudafrica 13
AR - Argentina 12
IE - Irlanda 12
IN - India 12
BJ - Benin 11
LA - Repubblica Popolare Democratica del Laos 11
AT - Austria 10
BF - Burkina Faso 10
BY - Bielorussia 10
CA - Canada 10
ES - Italia 10
CL - Cile 9
CO - Colombia 9
ME - Montenegro 9
PE - Perù 9
PK - Pakistan 9
YT - Mayotte 9
AD - Andorra 8
AO - Angola 8
DZ - Algeria 8
EE - Estonia 8
HR - Croazia 8
IS - Islanda 8
MG - Madagascar 8
MN - Mongolia 8
NO - Norvegia 8
PF - Polinesia Francese 8
PT - Portogallo 8
RE - Reunion 8
AZ - Azerbaigian 7
JM - Giamaica 7
JP - Giappone 7
LV - Lettonia 7
UG - Uganda 7
BD - Bangladesh 6
CY - Cipro 6
CZ - Repubblica Ceca 6
DJ - Gibuti 6
EG - Egitto 6
GN - Guinea 6
IL - Israele 6
IQ - Iraq 6
IR - Iran 6
KG - Kirghizistan 6
LC - Santa Lucia 6
LU - Lussemburgo 6
PH - Filippine 6
PR - Porto Rico 6
PY - Paraguay 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
ZW - Zimbabwe 6
AL - Albania 5
BO - Bolivia 5
BZ - Belize 5
CH - Svizzera 5
CV - Capo Verde 5
DK - Danimarca 5
GH - Ghana 5
GM - Gambi 5
HU - Ungheria 5
KE - Kenya 5
KR - Corea 5
MA - Marocco 5
ML - Mali 5
NI - Nicaragua 5
NP - Nepal 5
RS - Serbia 5
RW - Ruanda 5
TZ - Tanzania 5
VE - Venezuela 5
AM - Armenia 4
AU - Australia 4
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
CW - ???statistics.table.value.countryCode.CW??? 4
DM - Dominica 4
GA - Gabon 4
HT - Haiti 4
Totale 3.864
Città #
Ashburn 315
Fairfield 307
Singapore 193
Chandler 154
Houston 129
Cambridge 115
Woodbridge 114
Seattle 105
Ann Arbor 84
Wilmington 79
Hong Kong 72
Jacksonville 57
Dong Ket 50
Beijing 41
Santa Clara 41
Princeton 40
Boardman 35
Los Angeles 29
San Diego 25
New York 22
Ho Chi Minh City 19
Munich 18
Bytom 17
Nanjing 17
Abidjan 16
Helsinki 16
Medford 16
Buffalo 15
Washington 15
São Paulo 14
Padova 12
Roxbury 12
Cotonou 11
Dublin 11
Turku 11
Chicago 10
Dallas 9
Hanoi 9
Minsk 9
Vientiane 9
Changsha 8
Hefei 8
Johannesburg 8
Stockholm 8
Ulan Bator 8
Warsaw 8
Andorra la Vella 7
Des Moines 7
Kampala 7
Papeete 7
Podgorica 7
Reykjavik 7
Shenyang 7
Tallinn 7
Antananarivo 6
Baku 6
Conakry 6
Guayaquil 6
Harare 6
Hebei 6
London 6
Ouagadougou 6
Redondo Beach 6
The Dalles 6
Bamako 5
Banjul 5
Brooklyn 5
Castries 5
Dar es Salaam 5
Denver 5
Kigali 5
Managua 5
Milan 5
Nairobi 5
Riga 5
Vienna 5
Amman 4
Atlanta 4
Bishkek 4
Borås 4
Cabinda 4
Dakar 4
Djibouti 4
Frankfurt am Main 4
Istanbul 4
Jeddah 4
Libreville 4
Luanda 4
Lusaka 4
Luxembourg 4
Madrid 4
Mamoudzou 4
Mexico City 4
Norwalk 4
Nouakchott 4
Nuremberg 4
Padua 4
Phnom Penh 4
Roseau 4
Saint-Denis 4
Totale 2.593
Nome #
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 235
A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function. 212
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 198
Higher and lower active circulating VWF levels: different facets of von Willebrand disease 187
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 183
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 178
Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke 175
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. 167
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 160
Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease. 156
Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions. 154
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 152
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 147
Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. 143
Combined exon skipping and cryptic splice activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 138
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. 136
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 135
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 134
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? 130
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. 130
Haplotypes of Von Willebrand factor promoter predict thrombotic risk in Cushing's syndrome 128
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 126
Which assay is the most suitable to investigate von Willebrand factor functional activity? 124
Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding. 121
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 120
Identifying carriers of type 2N von Willebrand disease: procedures and significance. 107
Combined hemophilia A and type 2 von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor. 77
Totale 4.053
Categoria #
all - tutte 13.515
article - articoli 13.180
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021226 0 0 0 0 0 30 13 28 37 17 26 75
2021/2022364 16 29 70 18 6 29 16 43 10 6 53 68
2022/2023297 56 38 7 30 57 31 2 18 37 3 18 0
2023/2024205 2 27 32 17 29 38 20 3 1 7 18 11
2024/2025664 1 50 42 36 91 26 30 33 53 24 116 162
2025/20261.437 134 212 355 437 232 67 0 0 0 0 0 0
Totale 4.053